Duvi Honig appointed to HHS AI evaluation panel focused on advancing healthcare Innovation

HHS appoints Duvi Honig to a federal AI panel evaluating new technologies designed to improve the diagnosis and treatment of Lyme disease, Long COVID and other invisible illnesses.
The summary and context on this page were written by the Din Online desk based on the original article; any quotes are from the source. The full article and all rights to it remain with the source. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.